Search

Study designed to provide confirmational data on clinical benefits of SuperSaturated Oxygen Therapy for heart attack patients and financial benefits for healthcare organizations CHELMSFORD, Mass. -- ZOLL([R]), an Asahi Kasei [...]

Cumulative analysis of data up to 3.5 years from EXPLORER-LTE showed consistent and sustained improvements in echocardiographic measures and symptoms, with no new safety signals observed CAMZYOS is the first [...]

* EIB offers Protembis venture debt for next-generation technology to reduce risk of brain injury in patients undergoing catheter-based heart treatment * Financing is to complete clinical trials and support [...]

SAN CLEMENTE, Calif. -- Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in 'A pilot study of the Drug-Eluting Coronary Spur[TM] [...]

Designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease MILPITAS, Calif. -- Elixir Medical, a developer [...]

Digital hybrid platform with dedicated health coaches delivers significant improvements for heart patients; expands to all patients through ChristianaCare's Center for Virtual Health WILMINGTON, Del. -- ChristianaCare's Center for Heart [...]

* New patents in the United States, China, Japan and India * C. 150 international patents consolidate the company's position as a pioneer in fully implantable cardiac assist devices. * [...]

First In-Man Experience Exceeds Expectations, Cited as 'Game Changer' for Below-the-Knee Procedures CAMBRIDGE, Mass. -- Summa Therapeutics, LLC announced today that the first-in-man injectable angioplasty procedures for patients with below-knee [...]

Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate measurement of pulmonary pressure. LOS ANGELES -- Non-invasive cardiac [...]

* Trial will evaluate ilofotase alfa as a treatment to prevent renal damage in at-risk patients following open heart surgery * Ilofotase alfa's clinical record of renal protective effects supports [...]

HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia -- BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been [...]

Company's proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif. -- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused [...]

MASON, Ohio -- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced [...]

HART CVE test data presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting KIRKLAND, Wash. -- Prevencio, Inc., the AI-Powered Cardiac Blood Test Company, today announces the presentation of [...]

Severe Heart Failure patients to be treated with the FLOWMAKER[R], FineHeart's fully implantable breakthrough innovation to restore cardiac output. BORDEAUX, France -- FineHeart S.A, a medical device company developing innovative [...]

SANTA CLARA, Calif. -- PercAssist, Inc., a medical device company developing innovative technology for a minimally invasive, extravascular platform to provide hemodynamic support for chronic heart failure patients, today announced [...]

-- Next Generation DeepOCT[TM] and Near Infrared Spectroscopy Intravascular Imaging System Now Includes Expanded Toolkit to Optimize Coronary Stent Placement in the Cardiac Catheterization Lab -- BEDFORD, Mass. -- SpectraWAVE, [...]

- Zilebesiran Met Primary Endpoint Demonstrating Greater than 15 mmHg Reduction of Systolic Blood Pressure at Three Months of Treatment Compared to Placebo at Two Highest Single Doses Evaluated - [...]

KIRKLAND, Wash. -- Cardiac Dimensions([R]), a leader in the development of innovative, minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced [...]

Two successful clinic launches in Washington are yielding strong patient engagement and medication adherence for patients enrolled with congestive heart failure and hypertension. NEW YORK -- Cadence today announced a [...]

12 Month Data Presented as Late-Breaking Clinical Science at THT 2023 and Simultaneously Published in the Journal of Cardiac Failure BOSTON -- Ancora Heart, Inc., a company developing a completely [...]

-- Completion of enrollment for this 225-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate measurement of pulmonary pressure -- LOS [...]

KAIZEN to assess safety and efficacy of peripheral orbital atherectomy to secure regulatory approval in Japan ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company [...]

System includes mechanical and aspiration thrombectomy devices to treat peripheral vascular disease ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI([R])) (NASDAQ: CSII), a medical device company developing and commercializing innovative [...]

DANVERS, Mass. -- Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed's newest heart pump for patients experiencing [...]

HANOVER, Germany -- Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins its Board of [...]

Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals CHICAGO & SAN FRANCISCO -- AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS-- Viz.ai, the leader in AI-powered disease [...]

IRVINE, Calif. -- Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that a study [...]

ICOMS FLOWMAKER[R], First Fully Implantable Electro-Physiological Cardiac Assistance Device * Guillaume Buc, Chief Technical Officer * Sophie Jonquiere, Chief Procurement & Supply Chain Officer BORDEAUX, France -- FineHeart S.A, a [...]

ICOMS FLOWMAKER[R], First Fully Implantable Electro-Physiological Cardiac Assistance Device BORDEAUX, France -- FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER[R], a fully Implantable Cardiac Output [...]

Pre-specified pooled analysis from Phase III trials demonstrated reduction in CV death by 14% and reduction in death from any cause by 10% in patients with heart failure irrespective of [...]

Results presented at European Society of Cardiology Congress 2022, and published in New England Journal of Medicine Data extend the clinically meaningful benefits of FARXIGA in patients with heart failure [...]

SAN FRANCISCO -- Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, today announced the first patient [...]

Latest Data and Live Broadcast Show Promise of Vascular Dynamics' MobiusHD Device IRVINE, Calif. -- Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular [...]

IRVINE, Calif. -- Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, has announced the closing [...]

Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection Fraction SANTA CLARA, Calif. -- Ancora Heart, [...]

Company to focus on improving the quality of care for all cardiovascular patients in the U.S. ALISO VIEJO, Calif. -- On the heels of its landmark valvular heart disease (VHD) [...]

Results from the DELIVER and DAPA-HF Phase III trials demonstrate FARXIGA's efficacy in heart failure regardless of ejection fraction WILMINGTON, Del. -- High-level results from the DELIVER Phase III trial [...]

5,000 Patients Treated Globally DANVERS, Mass. -- The versatility and innovation of Abiomed's (NASDAQ: ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption [...]

* Full data set supports long-term use of Veltassa([R]) (patiromer) to control potassium buildup (hyperkalemia) in heart failure patients while on guideline-recommended RAASi therapy * Veltassa([R]) prevented the recurrence of [...]

ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI([R])) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced [...]

WellSky's technology platform and provider networks will coordinate the execution of in-home, heart failure protocols to lower hospital readmissions at The Ohio State University Wexner Medical Center OVERLAND PARK, Kan. [...]

Complementary technology to orbital atherectomy expands CSI's vessel prep market opportunity ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI([R])) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional [...]

Helping patients stick with their care plans and accurately communicate with their providers key to the best quality of life possible, says heart failure nurse specialist PORTLAND, Maine -- A [...]

Perceval Sutureless Aortic Heart Valve Received Approval in China to Treat Patients with Aortic Valve Disease LONDON -- CORCYM, the medical device company dedicated to providing patients and cardiac surgeons [...]

* Phase-IIIb trial demonstrates statistically significant outcome on the primary endpoint * Largest study to date showing benefit of Veltassa([R]) (patiromer) in high risk patient population with heart failure * [...]

KENILWORTH, N.J. -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the initiation of VICTOR (VerICiguaT in adults withChrOnicheart failure and Reduced ejection fraction), [...]

ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI([R])) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced [...]

DANVERS, Mass. -- The 2021 guidelines of the European Society of Cardiology (ESC) for treatment of acute heart failure patients, including patients in cardiogenic shock, raise the recommendation level for [...]

ST. PAUL, Minn. -- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced [...]